Please assess the completion status of the following clinical trial:

Trial Title: An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Dysfunctional immune system (reduced neutrophils).~* Confirmed Candida infection, defined as growth of Candida from a normally sterile site accompanied by signs and symptoms of infection.~* Male of female ≥16 years of age.~* Expected hospitalization for at least ten (10) days.~Exclusion Criteria:~* Pregnancy or breast feeding or planning to become pregnant during the study.~* Recent treatment with one of the study drugs over the last 30 days.~* Allergy to either study drug or to this class of drugs.~* Significant liver dysfunction.~* Suspected Candida osteomyelitis, endocarditis, meningitis or any other infections of the central nervous system.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Anidulafungin Arm (Type: EXPERIMENTAL): Subjects were randomized 2:1 (anidulafungin:caspofunin).
- Caspofungin Arm (Type: EXPERIMENTAL): Subjects were randomized 2:1 (anidulafungin:caspofunin).

Based on this trial design, predict the completion outcome and termination type (if applicable).